Prophylaxis vs. on‐demand treatment with Nuwiq^® (Human‐cl rh<scp>FVIII</scp>) in adults with severe haemophilia A

Abstract

Prophylaxis with Human-cl rhFVIII reduces recurrent bleeding in adult PTPs with severe haemophilia A and adds further supportive evidence for the benefits of prophylaxis in adults.